![](https://www.myelomaplatform.eu/wp-content/uploads/2023/01/e-learning-tumbnail3-1024x1024.webp)
Juggling the impact of disease, treatment, study participation on patients’ lives
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Fredrik-300x300-1.png)
Fredrik Schjesvold, MD, PhD
Oslo Myeloma Center, Hematologist,Department of Hematology, Norway
We all realize myeloma has a major impact on patients’ lives. But also treatments and participating in clinical studies can have a major influence. To what extent is this being discussed with patients?
This e-learning module zooms in on juggling the impact of the disease, treatment and/or participation in clinical studies on the quality of life.
Approximate time: 1 hour
Module 3: Juggling the impact of disease, treatment, study participation on patients’ lives
Accredited for 1 CME point
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Inger-300x300-1.png)
Inger Nijhof, MD, PhD
Hematologist,
St. Antonius Hospital,
Department of Internal Medicine,
The Netherlands
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Isabelle-300x300-1.png)
Isabelle Vande Broek, MD, PhD
Hematologist,
Vitaz, Sint-Niklaas,
Department of Oncology & Hematology,
Belgium
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Agoston-300x300-1.png)
Agoston Gyula Szabo , MD
Hematologist,
Righospitalet Copenhagen,
Department of Hematology,
Denmark
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Ville-300x300-1.png)
Ville Varmavuo, MD, PhD
Chief Medical Officer in Education,
Kotka,
Internal Medicine,
Finland
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Xavier-300x300-1.png)
Prof. Xavier Leleu, MD, PhD
Hematologist,
Academic Hospital of Poitiers,
France
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Valdas-300x300-1.png)
Valdas Peceliunas, MD
Hematologist,
Vilnius University Hospital Santaros Klinikos,
Department of Hematology,
Lithuania
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/Fredrik-300x300-1.png)
Fredrik Schjesvold, MD, PhD
Hematologist,
Oslo Myeloma Center,
Department of Hematology,
Norway
Accreditation
Accreditation for this e-learning has been granted for 3 points by:
European Accreditation Council for Continuing Medical Education (EACCME)
Obtain CME points
To obtain CME points, you must answer at least 70% of the questions in the final test correctly. If you have a lower score, you can retake the final test twice more. You can pause the e-learning and then resume where you paused.
Clinical cases
Throughout the e-learning challenging clinical cases from daily practice are being presented by the International Expert Panel.